Interferon-γ release assay in the diagnosis of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea

Clinical Rheumatology

Volumn 30, Issue 12, 2011, Pages 1535-1541

  Chang, Boksoon ^a   Park, Hye Yun ^a   Jeon, Kyeongman ^a   Ahn, Joong Kyong ^a   Cha, Hoon Suk ^a   Koh, Eun Mi ^a   Kang, Eun Suk ^a   Koh, Won Jung ^a  

^a Sungkyunkwan University   (South Korea)

Author keywords

Ankylosing spondylitis; Latent tuberculosis; Rheumatoid arthritis; Tuberculin test; Tumor necrosis factor alpha

Indexed keywords

ADALIMUMAB; BCG VACCINE; GAMMA INTERFERON; GLUCOCORTICOID; INFLIXIMAB; ISONIAZID; METHOTREXATE; RIFAMPICIN; TUBERCULOSTATIC AGENT; TUMOR NECROSIS FACTOR INHIBITOR;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTICLE; BCG VACCINATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CYTOKINE RELEASE; DRUG ERUPTION; FEMALE; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INTERFERON GAMMA RELEASE ASSAY; KOREA; LABORATORY DIAGNOSIS; LATENT TUBERCULOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUANTIFERON TB GOLD IN TUBE TEST; RHEUMATOID ARTHRITIS; SCAR; SCREENING TEST; THORAX RADIOGRAPHY; TREATMENT DURATION; TUBERCULIN TEST;

ADULT; ANTIBODIES, MONOCLONAL; ANTIBODIES, MONOCLONAL, HUMANIZED; ANTIRHEUMATIC AGENTS; ANTITUBERCULAR AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; IMMUNOGLOBULIN G; INTERFERON-GAMMA RELEASE TESTS; LATENT TUBERCULOSIS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; REPUBLIC OF KOREA; SPONDYLITIS, ANKYLOSING; TUBERCULIN TEST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 82655172620     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1771-9     Document Type: Article

References (36)

1. PE Lipsky DM van der Heijde EW St Clair DE Furst FC Breedveld JR Kalden JS Smolen M Weisman P Emery M Feldmann GR Harriman RN Maini 2000 Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group N Engl J Med 343 1594 1602 11096166 10.1056/NEJM200011303432202 1:CAS:528: DC%2BD3cXovVeltLk%3D (Pubitemid 32162982)
2. A Keat N Barkham A Bhalla K Gaffney H Marzo-Ortega S Paul F Rogers M Somerville R Sturrock P Wordsworth 2005 BSR guidelines for prescribing TNF-α blockers in adults with ankylosing spondylitis. Report of a working party of the British Society for Rheumatology Rheumatology (Oxford) 44 939 947 10.1093/rheumatology/keh669 1:STN:280:DC%2BD2MzjslGnuw%3D%3D (Pubitemid 41511193)
3. J Keane S Gershon RP Wise E Mirabile-Levens J Kasznica WD Schwieterman JN Siegel MM Braun 2001 Tuberculosis associated with infliximab, a tumor necrosis factor α-neutralizing agent N Engl J Med 345 1098 1104 11596589 10.1056/NEJMoa011110 1:CAS:528:DC%2BD3MXnsFShsr0%3D
4. JJ Gomez-Reino L Carmona VR Valverde EM Mola MD Montero 2003 Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report Arthritis Rheum 48 2122 2127 12905464 10.1002/art.11137 1:CAS:528:DC%2BD3sXntVWgsLc%3D (Pubitemid 36959191)
5. J Askling CM Fored L Brandt E Baecklund L Bertilsson L Coster P Geborek LT Jacobsson S Lindblad J Lysholm S Rantapaa-Dahlqvist T Saxne V Romanus L Klareskog N Feltelius 2005 Risk and case characteristics of tuberculosis in rheumatoid arthritis associated with tumor necrosis factor antagonists in Sweden Arthritis Rheum 52 1986 1992 15986370 10.1002/art.21137 1:CAS:528: DC%2BD2MXnsl2gsLY%3D (Pubitemid 40994319)
6. L Carmona JJ Gomez-Reino V Rodriguez-Valverde D Montero E Pascual-Gomez EM Mola L Carreno M Figueroa 2005 Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists Arthritis Rheum 52 1766 1772 15934089 10.1002/art.21043 1:CAS:528:DC%2BD2MXlvFChur0%3D (Pubitemid 40852885)
7. DE Furst EC Keystone R Fleischmann P Mease FC Breedveld JS Smolen JR Kalden J Braun B Bresnihan GR Burmester F De Benedetti T Dorner P Emery A Gibofsky A Kavanaugh B Kirkham MH Schiff J Sieper N Singer PL Van Riel ME Weinblatt MH Weisman K Winthrop 2010 Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2009 Ann Rheum Dis 69 Suppl 1 i2 i29 19995740 10.1136/ard.2009.123885 1:CAS:528:DC%2BC3cXhtFOlsbs%3D
8. I Solovic M Sester JJ Gomez-Reino HL Rieder S Ehlers HJ Milburn B Kampmann B Hellmich R Groves S Schreiber RS Wallis G Sotgiu EH Scholvinck D Goletti JP Zellweger R Diel L Carmona F Bartalesi P Ravn A Bossink R Duarte C Erkens J Clark GB Migliori C Lange 2010 The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Eur Respir J 36 1185 1206 20530046 10.1183/09031936.00028510 1:CAS:528: DC%2BC3MXhtVWqtA%3D%3D
9. X Mariette D Salmon 2003 French guidelines for diagnosis and treating latent and active tuberculosis in patients with RA treated with TNF blockers Ann Rheum Dis 62 791 12860745 10.1136/ard.62.8.791 1:STN:280:DC%2BD3szjtVWhsw%3D%3D (Pubitemid 36886422)
10. British Thoracic Society Standards of Care Committee 2005 BTS recommendations for assessing risk and for managing Mycobacterium tuberculosis infection and disease in patients due to start anti-TNF-α treatment Thorax 60 800 805 10.1136/thx.2005.046797 (Pubitemid 41475202)
11. JE Fonseca H Canhao C Silva C Miguel MJ Mediavilla A Teixeira W Castelao P Nero M Bernardes A Bernardo E Mariz F Godinho MJ Santos M Bogas M Oliveira MJ Saavedra A Barcelos M Cruz RA Santos L Mauricio M Rodrigues G Figueiredo A Quintal JV Patto A Malcata JC da Silva D Araujo F Ventura J Branco MV Queiroz 2006 Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience Acta Reumatol Port 31 247 253 17094336
12. PM Kavanagh JJ Gilmartin J O'Donnell D O'Flanagan 2008 Tumour necrosis factor-α and tuberculosis: guidance from the National TB Advisory Committee Ir Med J 101 6 7 18369014 1:STN:280:DC%2BD1c3htFehtA%3D%3D
13. D Ponce de Leon E Acevedo-Vasquez A Sanchez-Torres M Cucho J Alfaro R Perich C Pastor J Harrison C Sanchez-Schwartz 2005 Attenuated response to purified protein derivative in patients with rheumatoid arthritis: study in a population with a high prevalence of tuberculosis Ann Rheum Dis 64 1360 1361 16100342 10.1136/ard.2004.029041 1:CAS:528:DC%2BD2MXhtVChu7zE (Pubitemid 41206259)
14. M Pai A Zwerling D Menzies 2008 Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update Ann Intern Med 149 177 184 18593687
15. T Mori 2009 Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays J Infect Chemother 15 143 155 19554399 10.1007/s10156-009-0686-8 1:CAS:528:DC%2BD1MXns1CmtbY%3D
16. R Diel D Goletti G Ferrara G Bothamley D Cirillo B Kampmann C Lange M Losi R Markova GB Migliori A Nienhaus M Ruhwald D Wagner JP Zellweger E Huitric A Sandgren D Manissero 2011 Interferon-γ release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis Eur Respir J 37 88 99 21030451 10.1183/09031936.00115110 1:CAS:528:DC%2BC3MXjvVWhtr4%3D
17. J Sellam H Hamdi C Roy G Baron M Lemann X Puechal M Breban F Berenbaum M Humbert K Weldingh D Salmon P Ravaud D Emilie X Mariette 2007 Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy Ann Rheum Dis 66 1610 1615 17456528 10.1136/ard.2007.069799 (Pubitemid 350205449)
18. D Ponce de Leon E Acevedo-Vasquez S Alvizuri C Gutierrez M Cucho J Alfaro R Perich A Sanchez-Torres C Pastor C Sanchez-Schwartz M Medina R Gamboa M Ugarte 2008 Comparison of an interferon-γ assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population J Rheumatol 35 776 781 18398944 (Pubitemid 351747116)
19. G Matulis P Juni PM Villiger SD Gadola 2008 Detection of latent tuberculosis in immunosuppressed patients with autoimmune diseases: performance of a Mycobacterium tuberculosis antigen-specific interferon γ assay Ann Rheum Dis 67 84 90 17644549 10.1136/ard.2007.070789 1:CAS:528: DC%2BD1cXhs1ejtLk%3D
20. R Diel B Hauer R Loddenkemper B Manger K Kruger 2009 Recommendations for tuberculosis screening before initiation of TNF-α-inhibitor treatment in rheumatic diseases Pneumologie 63 329 334 19517358 10.1055/s-0029-1214673 1:STN:280:DC%2BD1Mvht1Wgsw%3D%3D
21. C Beglinger J Dudler C Mottet L Nicod F Seibold PM Villiger JP Zellweger 2007 Screening for tuberculosis infection before the initiation of an anti-TNF-α therapy Swiss Med Wkly 137 620 622 17990157
22. F Bartalesi S Vicidomini D Goletti C Fiorelli G Fiori D Melchiorre E Tortoli A Mantella M Benucci E Girardi MM Cerinic A Bartoloni 2009 QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases Eur Respir J 33 586 593 19047313 10.1183/09031936.00107608 1:STN:280:DC%2BD1M7nt1Cguw%3D%3D
23. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper LA Healey SR Kaplan MH Liang HS Luthra, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
24. S van der Linden HA Valkenburg A Cats 1984 Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria Arthritis Rheum 27 361 368 6231933 10.1002/art.1780270401 (Pubitemid 14134775)
25. JW Yun SY Lim GY Suh MP Chung H Kim OJ Kwon HS Cha EM Koh WJ Koh 2007 Diagnosis and treatment of latent tuberculosis infection in arthritis patients treated with tumor necrosis factor antagonists in Korea J Korean Med Sci 22 779 783 17982222 10.3346/jkms.2007.22.5.779 1:CAS:528:DC%2BD2sXhsVWrtLfO
26. GW Comstock LB Edwards RN Philip WA Winn 1964 A comparison in the United States of America of two tuberculins, Ppd-S and Rt 23 Bull World Health Organ 31 161 170 14253239 1:STN:280:DyaF2M%2FlslOgtQ%3D%3D
27. HL Rieder VK Chadha NJ Nagelkerke F van Leth MJ van der Werf 2011 Guidelines for conducting tuberculin skin test surveys in high-prevalence countries Int J Tuberc Lung Dis 15 Suppl 1 S1 S25 21276325
28. Fleiss J (1981) Statistical methods for rates and proportions. Wiley, New York, pp 212-236
29. G Valesini C Montecucco M Cutolo 2006 Recommendations for the use of biologic (TNF-α blocking) agents in the treatment of rheumatoid arthritis in Italy Clin Exp Rheumatol 24 413 423 16956432 1:STN:280:DC%2BD28rjt1eiuw%3D%3D (Pubitemid 44363543)
30. O Shovman M Anouk N Vinnitsky U Arad D Paran I Litinsky D Caspi O Elkayam 2009 QuantiFERON-TB Gold in the identification of latent tuberculosis infection in rheumatoid arthritis: a pilot study Int J Tuberc Lung Dis 13 1427 1432 19861018 1:STN:280:DC%2BD1MjitVSqsw%3D%3D
31. B Soborg M Ruhwald ML Hetland S Jacobsen AB Andersen N Milman VO Thomsen DV Jensen A Koch J Wohlfahrt P Ravn 2009 Comparison of screening procedures for Mycobacterium tuberculosis infection among patients with inflammatory diseases J Rheumatol 36 1876 1884 19648300 10.3899/jrheum.081292
32. R Diel R Loddenkemper S Niemann K Meywald-Walter A Nienhaus 2011 Negative and positive predictive value of a whole-blood interferon-γ release assay for developing active tuberculosis: an update Am J Respir Crit Care Med 183 88 95 20802162 10.1164/rccm.201006-0974OC 1:CAS:528:DC%2BC3MXhslOnsLc%3D
33. I Brock M Ruhwald B Lundgren H Westh LR Mathiesen P Ravn 2006 Latent tuberculosis in HIV positive, diagnosed by the M. tuberculosis specific interferon-gamma test Respir Res 7 56 16579856 10.1186/1465-9921-7-56 (Pubitemid 44131691)
34. G Ferrara M Losi M Meacci B Meccugni R Piro P Roversi BM Bergamini R D'Amico P Marchegiano F Rumpianesi LM Fabbri L Richeldi 2005 Routine hospital use of a new commercial whole blood interferon-γ assay for the diagnosis of tuberculosis infection Am J Respir Crit Care Med 172 631 635 15961696 10.1164/rccm.200502-196OC (Pubitemid 41232976)
35. Y Kobashi T Sugiu K Mouri Y Obase N Miyashita M Oka 2009 Indeterminate results of QuantiFERON TB-2 G test performed in routine clinical practice Eur Respir J 33 812 815 19129287 10.1183/09031936.00075008 1:CAS:528: DC%2BD1MXksl2ru74%3D
36. N Inanc SZ Aydin S Karakurt P Atagunduz S Yavuz H Direskeneli 2009 Agreement between Quantiferon-TB gold test and tuberculin skin test in the identification of latent tuberculosis infection in patients with rheumatoid arthritis and ankylosing spondylitis J Rheumatol 36 2675 2681 19918035 10.3899/jrheum.090268